PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ipratropium bromide - Allergic rhinitis
PAD Profile : Ipratropium bromide - Allergic rhinitis
Keywords :
Hay fever, hayfever, nasal sprays, allergy, seasonal allergic rhinitis, pollen allergy, rhinorrhoea, intranasal antimuscarinic, runny nose, watery rhinorrhoea
Brand Names Include :
Rinatec
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Fluticasone furoate
- Cetirizine hydrochloride
- Loratadine
- Triamcinolone acetonide
- Beclometasone dipropionate
- Azelastine hydrochloride
- Desloratadine
- Levocetirizine
- Budesonide
- Mometasone furoate
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Mometasone furoate/olopatadine hydrochloride
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
- Fluticasone propionate (Nasal)
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Intranasal ipratropium is an add-on treatment option for those with a runny nose associated with allergic rhinitis.
Use in caution in those at risk of closed angle glaucoma
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.02.01. Drugs used in nasal allergy